Courses Teach Scientists To Sell Their Ideas, Manage Others

A consumer-products company had the formula for hairstyling mousse in its files nearly two years before the product was introduced on the market by a competitor. When the company finally brought out its own mousse, a year after the competitor’s product debuted, it was able to garner only about 15% of the market share. Industrial psychologist Bernard Rosenbaum remembers being told by the head of research and development that the firm’s failure to be the first on the market “w

Written byBarbara Spector
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

A consumer-products company had the formula for hairstyling mousse in its files nearly two years before the product was introduced on the market by a competitor. When the company finally brought out its own mousse, a year after the competitor’s product debuted, it was able to garner only about 15% of the market share. Industrial psychologist Bernard Rosenbaum remembers being told by the head of research and development that the firm’s failure to be the first on the market “was solely because of [R&D’s] inability to present the concept at the product-development meeting.”

A manufacturer of testing equipment for the microchip industry was asked by a customer to revise its testing device to accommodate twice as many chips. When the manufacturer failed to come up with the requested product, the customer developed its own equipment, which it then introduced on the market. “The customer became the competitor,” Rosenbaum recalls, and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies